BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2201 related articles for article (PubMed ID: 19295407)

  • 21. [Role of HPV DNA detection and p16(INK4A) protein expression in diagnosis of endocervical adenocarcinoma].
    Meng ZL; Guo LN; Luo YF; Cao JL; Wan JW; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):810-3. PubMed ID: 18346352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P16 as a molecular biomarker of cervical adenocarcinoma.
    Schorge JO; Lea JS; Elias KJ; Rajanbabu R; Coleman RL; Miller DS; Ashfaq R
    Am J Obstet Gynecol; 2004 Mar; 190(3):668-73. PubMed ID: 15041997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
    Ferguson AW; Svoboda-Newman SM; Frank TS
    Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-grade mucinous adenocarcinoma of the uterine corpus: a rare and deceptively bland form of endometrial carcinoma.
    Fujiwara M; Longacre TA
    Am J Surg Pathol; 2011 Apr; 35(4):537-44. PubMed ID: 21378544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal expression of sex steroid receptors and cell cycle-related molecules in adenocarcinoma in situ of the uterine cervix.
    Lu X; Shiozawa T; Nakayama K; Toki T; Nikaido T; Fujii S
    Int J Gynecol Pathol; 1999 Apr; 18(2):109-14. PubMed ID: 10202666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between adenocarcinoma in both endocervical and endometrial specimens from fractional curettage and pathologic findings in subsequent hysterectomy specimens.
    Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
    J Med Assoc Thai; 2008 Sep; 91(9):1313-7. PubMed ID: 18843857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
    Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
    Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Hsu JD; Yao CC; Lee MY; Kok LF; Wang PH; Tyan YS; Han CP
    Int J Gynecol Pathol; 2010 May; 29(3):282-9. PubMed ID: 20407331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
    Walts AE; Lechago J; Bose S
    Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
    Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
    Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of HPV DNA typing in the distinction between adenocarcinoma of endocervical and endometrial origin.
    Plunkett M; Brestovac B; Thompson J; Sterrett G; Filion P; Smith D; Frost F
    Pathology; 2003 Oct; 35(5):397-401. PubMed ID: 14555383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship with human papilloma virus DNA in cervical adenocarcinoma].
    Ogura K; Ishi K; Suzuki F; Suto H; Kina K; Koyatsu J; Nojima M; Yoshida K; Suda K
    Rinsho Byori; 2004 Feb; 52(2):115-9. PubMed ID: 15027314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases.
    McCluggage WG; Hurrell DP; Kennedy K
    Am J Surg Pathol; 2010 May; 34(5):735-41. PubMed ID: 20414103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus in lung carcinomas among three Latin American countries.
    Castillo A; Aguayo F; Koriyama C; Shuyama K; Akiba S; Herrera-Goepfert R; Carrascal E; Klinge G; Sánchez J; Eizuru Y
    Oncol Rep; 2006 Apr; 15(4):883-8. PubMed ID: 16525675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.
    Pirog EC; Kleter B; Olgac S; Bobkiewicz P; Lindeman J; Quint WG; Richart RM; Isacson C
    Am J Pathol; 2000 Oct; 157(4):1055-62. PubMed ID: 11021808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus-Positive and Human Papillomavirus-Negative Tumors.
    Pirog EC
    Arch Pathol Lab Med; 2017 Dec; 141(12):1653-1667. PubMed ID: 28644686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of HPV, steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and inhibin/activin subunits (alpha, betaA and betaB) in adenosquamous endometrial carcinoma.
    Gingelmaier A; Gutsche S; Mylonas I; Shabani N; Kuhn C; Kunze S; Jeschke U; Friese K
    Anticancer Res; 2007; 27(4A):2011-7. PubMed ID: 17649814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
    Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
    Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 111.